Xenous Holdings, Inc. Announces Change in Leadership: CEO Resignation and Appointment
Key Highlights:
- Xenous Holdings, Inc. (OTC: XITO) filed a Form 8-K on May 12, 2026, announcing a significant leadership change.
- Jonathan Chan Ye Earn, the Chief Executive Officer and Director, resigned effective May 8, 2026.
- Mr. Chan’s resignation was not due to any disagreement regarding the company’s operations, policies, or practices.
- Dingwen Zhang has been appointed as the new Chief Executive Officer and Director.
- There are no employment agreements, compensation, or related benefits for Mr. Zhang at this time.
Detailed Article:
Xenous Holdings, Inc., trading under the symbol XITO on the OTC, has reported a major change in its executive leadership. On May 8, 2026, Jonathan Chan Ye Earn tendered his resignation as Chief Executive Officer and Director. According to the company’s filing, Mr. Chan’s departure was amicable and not related to any disputes with the company’s board or management, nor due to operational or policy disagreements.
The resignation of Mr. Chan marks a pivotal moment for Xenous Holdings, as leadership transitions often carry implications for a company’s strategic direction and investor confidence. Shareholders should note that such changes can be price sensitive, especially when the outgoing CEO has played a key role in the company’s operations and vision.
Following Mr. Chan’s departure, Dingwen Zhang has been appointed to fill the position of Chief Executive Officer and Director. Mr. Zhang brings a robust entrepreneurial and financial background to Xenous Holdings. Since June 2023, he has served as founder and CEO of Soon Fund, and since January 2023, as Managing Director of QMetaVerse. He also founded Beishang Capital (Shenzhen) Group Co., Ltd. in October 2020. Mr. Zhang holds a Bachelor of Finance from Tsinghua University, PRC, earned in 2018.
Investors should note that Mr. Zhang has no family relationships with any current executive officers or directors at Xenous Holdings. The company explicitly states that there are no employment agreements, nor are there arrangements for compensation, bonuses, pensions, retirement, or similar benefits for Mr. Zhang at this time. Furthermore, there have been no transactions involving Mr. Zhang that would present a direct or indirect material interest.
While the company has attached a referenced agreement (Exhibit 10.1) to the 8-K report, the summary states that the description of this agreement is qualified in its entirety by reference to the actual text of the agreement. Investors may wish to review Exhibit 10.1 for further details, but as of this filing, no compensatory arrangements are in place for the new CEO.
Corporate and Shareholder Information:
- Xenous Holdings, Inc. is incorporated in Nevada (NV).
- Principal executive offices are located at Room 1120, 11th Floor, Peninsula Centre, 67 Mody Road, East Kowloon, Hong Kong.
- Contact number: +852 6464-2017.
- Common Stock trades under the ticker symbol XITO on the OTC market.
- Entity Tax Identification Number: 87-0363526.
Implications for Shareholders:
Leadership changes, especially at the CEO level, are often closely watched by the market and can influence investor sentiment and share price. The appointment of Mr. Zhang, given his experience in finance and technology, may signal a shift in corporate strategy or operational focus, which could be material to the company’s future performance. The absence of a formal compensation package or employment agreement suggests the board may be considering performance-based incentives or is in the process of negotiating terms.
Shareholders should monitor further announcements, including details from Exhibit 10.1 and any subsequent filings or statements from the company, to gain a clearer understanding of Xenous Holdings’ strategic direction under its new leadership.
Disclaimer:
This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Investors should conduct their own due diligence and consult with financial advisors before making any investment decisions. The information herein is based on publicly available filings and may be subject to change or clarification by Xenous Holdings, Inc.
